Alibaba Breaking Into Healthcare Market
Chinese multinational e-commerce and retail giant Alibaba will place some of its online pharmacy business into a listed unit in a deal valued at HK$10.6 billion ($1.35 billion), with Alibaba healthcare breaking into the market.
This new deal will see Alibaba receive newly issued shares in Ali Health, taking its economic interest in the firm to 56.2% from 48.1% currently. After this deal, the company will also have a 67.5% voting interest in Ali Health.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Healthcare. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Healthcare and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Healthcare?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
According to Alibaba, the deal was subject to approval from Ali Health shareholders as well as the Hong Kong stock exchange. The deal can help Ali Health increase their business amid a broader push into a fast-growing healthcare technology market by other firms in China like Ping An Healthcare.
Alibaba CEO Daniel Zhang said that healthcare was a “strategically important” business area for the firm and that the deal would help turn Ali Health into the country’s “best healthcare ecosystem”. He added that the deal would help the firm expand by adding new categories to its offering. Many technology firms are aiming to break into the rapidly growing private health market. Chinese healthcare spending is set to hit $1 trillion by 2020, up from $357 billion in 2011.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
